The EPHA2 gene encoding erythropoietin-producing hepatocellular A2 (EphA2) plays a significant role in cancer progression through neovascularization [82] while silencing of EPHA2 in human gastric cancer cells in vitro and in vivo decreased cell invasion, thus inhibiting cancer cell progression [83]. This evidence concerns the gene EPHA2 and gastric cancer.